Excedrin Quick Tabs TV Spots Easy to Swallow

Bittar, Christine
September 2002
Brandweek;9/2/2002, Vol. 43 Issue 31, p5
Trade Publication
Reports on the marketing campaign to be used by Bristol Myers-Squibb for the launch of its Excedrin Quick Tabs, an analgesic that melts in the mouth. Description of the television spots; Tagline for the spots; Budget for the campaign; Sales expected for the product.


Related Articles

  • Celebrity Hearts Go Out In Bristol-Myers Effort. Bittar, Christine // Brandweek;11/12/2001, Vol. 42 Issue 42, p10 

    Reports on the public awareness and research campaign of Bristol-Myers Squibb Co. in November 2001. Estimated cost of the campaign; Information on prescription cholesterol drug Pravachol from Bristol; Features of the print campaign created by agency Robert A. Becker/Euro RSCG, New York.

  • BMS ups DTC to fend off generic Plavix. Iskowitz, Marc // Medical Marketing & Media;Nov2006, Vol. 41 Issue 11, p28 

    The article reports on the plan of Bristol-Myers Squibb Co. to expand the direct-to-consumer advertising for its Plavix in the U.S. The move is intended to counter the impact of the launching of its generic. Lamberto Andreotti, executive vice president and president, claims that the campaign...

  • Bristol-Myers Squibb plans fall campaign for Plavix. Goetzl, David // Advertising Age;6/26/2000, Vol. 71 Issue 27, p36 

    Reports that Bristol-Myers Squibb plans to launch a direct-to-consumer advertising campaign for Plavix, a heart attack and stroke prevention drug. Obstacles faced by Bristol-Myers before the ad campaign can begin, including the resolution of potential health side effects associated with Plavix;...

  • Keri Takes Firming Tack In `Last Chance' Revival. Bittar, Christine // Brandweek;12/13/99, Vol. 40 Issue 47, p8 

    Highlights the advertising campaign of Keri Skin Renewal Lotion from Bristol-Myers Squibb. Advertising budget; Competition with Nivea; Sales of Bristol-Myers; Tagline.

  • BMS shops $20 mil. account. Kim, Hank; Comiteau, Jennifer // Adweek Southeast Edition;11/03/97, Vol. 18 Issue 44, p67 

    Reports on rumors that Bristol-Myers Squibb has contacted at least one agency about its Vagistat-1 advertising account in 1997. Move as part of Bristol-Myers' reassessment of the remainder of its business currently at Wells; Reason behind this reappraisal.

  • Bristol-Myers Squibb sets Vagistat-1 review.  // Advertising Age;10/28/1996, Vol. 67 Issue 44, p1 

    Informs that Bristol-Myers Squibb Co. is conducting a review for Vagistate-1. Reduced time treatment for yeast infection; Awaiting approval from US Food and Drug Administration.

  • Our Online Survey.  // Advertising Age;6/27/2005, Vol. 76 Issue 26, p18 

    Presents the results of an online survey regarding the advertisement of drugs. Percentage of those surveyed who think Big Pharma should embrace a voluntary moratorium on advertising drugs; Proportion of respondents who say that large pharmaceutical companies should not follow Bristol-Myers...

  • LATE NEWS.  // Advertising Age;3/24/2003, Vol. 74 Issue 12, p1 

    The article reports on developments relevant to advertising and marketing in the United States as of March 24, 2003. Key issues discussed include the Treasury Department's proposed changes to the definition of malt beverages and the advertising campaign of Bristol Myers for its Excedrin...

  • PRIVATE VIEW. Coldiron, Steve // Medical Marketing & Media;Aug2009, Vol. 44 Issue 8, p64 

    The article offers information on perspectives shared by companies regarding the non-branded advertisement for Hepatitis B created by Corbett Worldwide Healthcare Communications for Bristol-Myers Squibb and fibromyalgia awareness created by Euro RSCG Life ML&P for Pfizer in the U.S. According to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics